Sort by
Refine Your Search
-
PhD in Pharmacometrics, Clinical Pharmacology, Pharmacokinetics, Engineering, Pharmaceutical Sciences, or PharmD Strong written and verbal communication skills PREFERRED QUALIFICATIONS Experience
-
stability. This position will closely collaborate with colleagues across PharmSci as well as with partners in Medicinal Chemistry, Pharmacokinetics & Drug Metabolism, and Clinical Pharmacology. You will be
-
ROLE SUMMARY As a member of our Oncology Research Unit (ORU) In Vivo Pharmacology and Project Leadership group, you will lead a group focused on developing and implementing in vivo strategies
-
/Biostatistics or related field with 8+ years' experience or PhD in Statistics/Biostatistics or related field with 5+ years' experience in clinical trials Understanding of broad statistical theory and its
-
Oncology first-in-human clinical trials with input from Oncology Research Unit, Oncology Regulatory Strategy, Clinical Pharmacology and Precision Medicine, Oncology Clinical Development and Operations, Pharm
-
clinicians or contingent workers assigned to the project; may supervise, mentor, and/or develop others. QUALIFICATIONS Science degree (PhD, PharmD) and minimum of 9 years Clinical Research experience in
-
translation of pre-clinical observations into clinical experiments and studies designed to demonstrate proof of pharmacology, proof of mechanism and proof of concept for new candidate medicines. The CL will
-
approaches. You will partner with key stakeholders and colleagues in Clinical Pharmacology, Quantitative Systems Pharmacology, Statistics, Translational Modeling and Simulation, and other Research and
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
clinical development and commercial priorities for Pfizer Oncology. QUALIFICATIONS: Education MD, MD/PhD or equivalent with extensive clinical experience. Experience 10+ years of oncology development